Horsham, PA, USA (Vocus) June 17, 2009
The 45th Annual Meeting provides access to more than 350 sessions focusing on issues in global drug discovery and development, three megatracks in IT, clinical research, and advertising/marketing/medical communications, and the industry's largest interactive exhibit hall.
- Monday's multi-track plenary session, Improving Safety with Every Step: Pillars of the Pharmaceutical Landscape
- Current event sessions
- Hot topics! Phase 1 Early Development, Accelerated Development Time, US FDA Sentinel Initiative, Transparency, Pharmacogenomics and Personalized Medicines and much more!
- Pharma in the New Age of Transparency
- Meet the Regulators
- CDER Town Meeting Parts 1 and 2
- European Medicines Agency Town Hall
One-day registrants have access to all preconference PowerPoint presentations of sessions that occur the day for which they are registered. Preconference presentations are available online until 12:00PM PST, Thursday, June 25. In addition, one-day registrants receive access to audio-synchronized PowerPoint presentations through DIA's Live Learning Center (LLC) following the 45th Annual Meeting.
The 45th Annual Meeting is the biopharmaceutical industry's largest and longest running global, multidisciplinary conference featuring sessions and preconference tutorials on issues affecting drug discovery and development, including two timely sessions reflecting the state of today's global biopharmaceutical environment.
About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team.
Clearpoint Agency, Inc.
# # #